Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 539428 | NSE Symbol : | ISIN : INE030T01027 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
07-Apr-2025	15-Apr-2025	Right Issue	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/04/2025 ,inter alia, to consider and approve In compliance with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the company is scheduled to be held on Saturday, April 12, 2025 to discuss the following agenda, including but not limited to: 1. To consider, take on record and approve the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company. 2. To Consider Change in Registered o??ice of the company within the local limits of same Town & City. 3. Any other matter with permission of Chairman of the meeting. Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2025 ,inter alia, to consider and approve We wish to inform you that the Meeting of the Board of Directors of the company was schedule to be held on Saturday, April 12, 2025 postponed to Tuesday, 15th April 2025 to discuss the following agenda, including but not limited to: 1. To consider, take on record and approve the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company. (As Per Bse Announcement Dated on 12.04.2025) In continuation of earlier intimation dated April 9, 2025, in compliance with Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it was informed that the Meeting of the Board of Directors of the company is scheduled to be held on Tuesday, April 15, 2025 to discuss, inter alia, the Draft Letter of Offer in relation to the proposed Right Issue of Equity Shares by the Company, we have to inform that the Board after careful consideration of the draft letter offer for the proposed rights issue upto Rs. 725 lakhs and matters incidental or consequential thereto, approved the draft letter and authorized its filing on-line with BSE for their approval, the designated Stock Exchange as per applicable provisions of SEBI ICDR, 2018. (As Per Bse Announcement Dated on 15.04.2025)
03-Feb-2025	11-Feb-2025	Quarterly Results	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 11th February 2025 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter Ended on 31st December 2024. 2. Any other matter with the permission of the Chair. We hereby inform you that the Board of Directors of the Company in its meeting held today on February 11, 2025, have, inter alia, considered and approved the following matters: 1. The Board considered the proposal to expand/modernize the business of the company. 2. The Board considered the revised proposal for fund raising by the company for above expansion / modernization through the proposed rights issue from a sum not exceeding Rs. 700 lakhs to Rs. 750 lakhs to the eligible equity shareholders of the Company in accordance with the applicable laws subject to regulatory approval, if any as intimated earlier. 3. The Board considered the unaudited financial result with limited review for the nine months period ended 31st December 2024 and authorized its Managing Director to taking required action for its publication in accordance with requirements of SEBILODR, 2015. The Board meeting commenced at 7.00 pm and concluded at 11.00 pm (As Per BSE Announcement Dated on: 11.02.2025)
17-Jan-2025	23-Jan-2025	Increase in Authorised Capital	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve Please refer the letter dated as on 17/01/2025 for the upcoming meeting of the board to consider important matters of the company. Please refer board outcome in the letter attached (As per BSE Announcement Dated on 23/01/2025) Revision of Outcome of the board meeting held on 23rd January 2025. Due to Inadvertence/Typographical error proposed right issue approved by the board was mentioned as Rs 500 lakhs in the announcement made previously but it should be Rs 700 lakhs Please refer revised outcome for your reference. (As Per BSE Announcement Dated on 24/01/2025)
07-Nov-2024	14-Nov-2024	Quarterly Results	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter and Half year Ended on 30th September 2024. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 7th November 2024, we wish to inform you that a meeting of the Board of Directors of the Company was held on Thursday, 14th November 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikhroli - West, Mumbai - 400079 at 5.00 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2024 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting of Board of Directors commenced at 5:00 p.m. and concluded at 11.00 pm (As Per Bse Announcement Dated on 14.11.2024)
06-Aug-2024	14-Aug-2024	Quarterly Results	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th June 2024. 2. Any other matter with the permission of the Chair. 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for thequarter ended on 30th June 2024 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Took on record the resignation letter dated August 14th ,2024 received from M/s PD Dalal & Co. (FRN: 102047W) from the post of Statutory Auditor of the Company w.e.f. August 14th, 2024, due to other commitments and that there is no other material reason for the resignation. 3. Recommendation for appointment of M/s. Maheshwari & Co., Chartered Accountants (Firm Registration No.: 105834W), Mumbai as the Statutory Auditors the meeting of Board of Directors commenced at 12.00 p.m. and concluded at 3.00p.m (As per BSE Announcement dated on 14/08/2024)
17-May-2024	28-May-2024	Accounts	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1. To Consider and approve Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31, 2024. 2. Any other matter with the permission of the Chair. We wish to inform you that the meeting of the Board of Directors of the Company held Today i.e. Tuesday, May 28, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 2 p.m., and has transacted the following businesses: 1. Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2024 and Auditors Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2024. - The meeting of Board of Directors commenced at 2.00 pm and concluded at 5.30 pm. Read less.. (As Per BSE Announcement Dated on 28.05.2024)
05-Feb-2024	12-Feb-2024	Quarterly Results	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Monday 12TH February 2024 at A 601 Floor No.6 Kailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Gtandalone & Consolidated) for the Quarter Ended on 31st December 2023. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 5th February, 2024 we wish to inform you that a meeting of the Board of Directors of the Company was held on Monday, 12th February, 2024 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 5.30 p.m. and has transacted the following: - 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 31st December 2023 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 5.30 p.m. and concluded at 9.30 pm Please Find Attached Result (As per BSE Announcement Dated on 12/02/2024)
02-Nov-2023	11-Nov-2023	Quarterly Results	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday 11th November 2023 at A 601 Floor No.6 Kailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter and Half year Ended on 30th September 2023. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 2nd November, 2023 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 11th November, 2023 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 4.00 p.m. and has transacted the following:- 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th September 2023 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 4.00 p.m. and concluded at 5.00 pm (As Per BSE Announcement dated on 11.11.2023)
05-Aug-2023	12-Aug-2023	Quarterly Results	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday 12th August 2023 at A 601 Floor No.6 Kailash Business Park Veer Savarkar Marg Vikroli - West Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter 30th June 2023. 2. Any other matter with the permission of the Chair. Further in terms of the Provision of the SEBI (Prohibition of Insider Trading) Regulation 2015 Intimation for the closure of trading window of the company for dealing in the shares of the Company was given vide intimation letter dated 26th June 2023 till expiry of 48 hours after the declaration of Un-audited financial results of the Company for the quarter ended 30th June 2023. In continuation of our Letter dated 05th August, 2023 we wish to inform you that a meeting of the Board of Directors of the Company was held on Saturday, 12th August, 2023at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 5.30 p.m.and has transacted the following:- 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended on 30th June 2023 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; The meeting of Board of Directors commenced at 5.30 p.m. and concluded at 10:30 p.m. (As Per BSE Announcement Dated on 12.08.2023)
29-Jun-2023	29-Jun-2023	Stock Split	Outcome of Board Meeting to decide Record Date for the purpose of sub-division/split of shares.
09-May-2023	20-May-2023	Accounts	Audited Results & Stock Split Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday, May 20, 2023 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 to transact the business as given below: 1. To Consider and approve Audited Financial Results (Standalone & Consolidated) for the Quarter and year ended March 31, 2023; 2. To consider sub-division (Change in Face Value) of equity share of the Company. 3. To consider the agenda with respect to Change of Registrar and Share Transfer Agent of the Company. 4. To Consider and Approve the Appointment of Internal Auditor. The Board of Directors Considered and approved the agenda with respect to Change of Registrar and Share Transfer Agent of the Company. The Board of Directors Considered and approved the agenda with respect to Change of Registrar and Share Transfer Agent of the Company. We wish to inform you that the meeting of the Board of Directors of the Company held Today ie. Saturday, May 20, 2023atA 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 03:00 p-m. and Concluded at 5 pm and has transacted the following businesses attached in the PDF The Board of Director have Considered and approved the Appointment of the Firm 'Kapil Tulsani & Associates' as an Internal Auditor of the Company. The Board of Director have Considered and approved the proposal of sub-division of Equity Share having face value of Rs. 10 /- each fully paid up into Equity Shares having face value of Rs. 5/-each fully paid up at the record date to be decided by Board of Directors, subsequent to the approval of shareholders through Postal Ballot (e-voting process). (As Per BSE Announcement Dated on 20.05.2023)
30-Jan-2023	11-Feb-2023	Quarterly Results	Quarterly Results & Stock Split Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 ,inter alia, to consider and approve a. Un-audited financial result (Standalone and Consolidated) for quarter ended on December 31, 2022; b. Sub-division of (Change in face value) of equity share of the Company; c. The Appointment of Mr. Nandish Dave, Company Secretary as a Secretarial Auditor of the Company for FY 2022-23; d. Any other matter with the permission of the Chair. With Reference to the subject cited above; we wish to inform you that a meeting of the Board of Directors of the Company held on Saturday February 11, 2023 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 5.00 p.m. and has transacted the following:- 1. Considered and approved Un-Audited Financial Results (Standalone & Consolidated) for the Quarter ended on December 31, 2022 and took note of Limited Review Report thereon, in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; 2. Due to non working of MCA portal; Board has decided to put the agenda related to Splitting/ Sub-division of share on hold for today but to start the process as soon as the portal is functional 3. Considered and approved the Appointment of CS Nandish Dave (Prop. of N S Dave and Associates) as a Secretarial Auditor and other Secretarial Task for financial year 2022-23. Please find the enclosed herewith Unaudited Financial Results (Standalone & Consolidated) for the Quarter ended on December 31, 2022 along with Limited Review Report thereon approved by the Board of Directors of the Company at its Meeting held on Saturday, February 11, 2023 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 5.00p.m., in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and record. (As Per BSE Announcement Dated on 11.02.2023) In compliance of provision of Regulation 47 read with Regulation 33 of the SEBI (LODR) Regulations, 2015, the Company has published the Un-Audited Financial Results for the quarter ended on 31st December, 2022 which has been approved by Board of Directors at the Board Meeting held on February 11, 2023. The financial results were published in 'Active Times' (English Newspaper) and 'Mumbai Lakshadweep' (Marathi Newspaper), on 13th February, 2023. Kindly take the same on your record. (As Per BSE Announcement Dated on 13/02/2023)
31-Oct-2022	07-Nov-2022	Quarterly Results	Quarterly Results Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve Un-Audited Financial Results (Standalone & Consolidated) for the Quarter and Half year Ended on 30th September 2022 Any other matter with the permission of the Chair. (As Per BSE Announcement Dated on 28.10.2022) In continuation of our Letter dated 28th October 2022 we wish to inform you that a meeting of the Board of Directors of the Company was held on Monday, 07th November, 2022at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikhroli - West, Mumbai - 400079 commenced at 5.00 p.m. and concluded at 7.30 pm (As Per BSE Announcement Dated on 07.11.2022)
03-Aug-2022	11-Aug-2022	Quarterly Results	Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 inter alia to consider and approve 1. To Consider and approve Un-audited Financial Results (Standalone & Consolidated) for the Quarter ended 30th June 2022. 2. Any other matter with the permission of the Chair. In continuation of our Letter dated 02TH August, 2022,We wish to inform you that a meeting of the Board of Directors of the Company was held on Thursday, 11TH August, 2022 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 12.00 p.m. (As Per BSE Announcement Dated 11.08.2022)
10-May-2022	17-May-2022	Accounts	Audited Results In continuation of our Letter dated 8th May, 2022,we wish to inform you that a meeting of the Board of Directors of the Company was held on Tuesday, 13th May 2022 at A 601, Floor No.6, Kailash Business Park, Veer Savarkar Marg, Vikroli - West, Mumbai - 400079 at 6.00 pm (As Per BSE Announcement Dated on 17.05.2022)

1 2

LOGIN HERE

Tejnaksh Healthcare Ltd

Board Meeting